Global Behavioral Health

Behavioral Health Comprehensive Study by Type (Depression, Anxiety, Schizophrenia, Alcohol Use Disorders, Others), Service (Emergency Mental Health Services, Outpatient Counseling, Home-Based Treatment Services, Inpatient Hospital Treatment Services, Preventative Programs), Age Group (Pediatric Mental Health, Adult Mental Health, Geriatric Mental Health), Disorder (Mental Health, Substance Abuse, Trauma and PTSD), Payor (Public Health Insurance, Private Health Insurance, Out of Pockets) Players and Region - Global Market Outlook to 2029

Behavioral Health Market by XX Submarkets | Forecast Years 2024-2029  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Behavioral Health
Behavioral health refers to the scientific study of the behaviors, emotions, and biology relating to a mental well-being of a person, their ability of functioning in everyday life and their concept of the self. “Behavioral health” is a preferred term to the “mental health.” A person who is struggling with his or her behavioral health may face depression, stress, anxiety, relationship problems, addiction, grief, ADHD or learning disabilities, mood disorders, or other psychological concerns. There are various techniques used in the treatment of an individual in behavioral health. The therapists study the human behavior to change the bad habits with good one. Also, it is performed to find a solution for certain kinds of phobias, stress as well as bipolar disorder among others. According to the World Health Organization, behavioral health is defined as a state of well-being in which every individual realizes his or her own potential, can cope with the normal stresses of life, can work productively and fruitfully, and is able to make a contribution to her or his community.

AttributesDetails
Study Period2019-2029
Base Year2023
UnitValue (USD Million)


The competitive landscape in Behavioral Health is constantly evolving, with new players emerging and traditional ones adapting. Understanding these dynamics is crucial for any organization involved in this sector to stay ahead of the curve and deliver impactful services to those in need. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Behavioral Health market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Eli Lilly and Company (United States), AstraZeneca PLC (United Kingdom), Pfizer Inc.(United States), Novartis AG (Switzerland), NeuroSky (United States), Masimo Corporation (United States), Cephalon (United States) and GlaxoSmithKline plc (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Talkspace (United States), Calm (United States), GeneSight (United States) and Mindfull (United States).

Segmentation Overview
AMA Research has segmented the market of Global Behavioral Health market by Type (Depression, Anxiety, Schizophrenia, Alcohol Use Disorders and Others) and Region.



On the basis of geography, the market of Behavioral Health has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Service, the sub-segment i.e. Emergency Mental Health Services will boost the Behavioral Health market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Age Group, the sub-segment i.e. Pediatric Mental Health will boost the Behavioral Health market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disorder, the sub-segment i.e. Mental Health will boost the Behavioral Health market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Payor, the sub-segment i.e. Public Health Insurance will boost the Behavioral Health market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Preferences of Partial Hospitalization Programs (PHP), Advent of Online Counselling and Emergence of Behavioral Software

Market Growth Drivers:
Increasing Number of People Who Are Suffering From Behavioral Health and Growing Accessibility of Therapies for Behavioral Health

Challenges:
Lack Of Awareness in Developing Countries and Time-Consuming Procedures

Restraints:
Dearth of Awareness of Behavioral Health and Lack of Proper Reimbursement

Opportunities:
Technological Advancement in Healthcare Expenditure in Emerging Economics

Market Leaders and their expansionary development strategies
In October 2023, Headspace and Spotify entered into this strategic alliance which integrates Headspace's mindfulness content into Spotify's premium subscription tier, making mindful practices readily accessible to a wider audience through music streaming.
In July 2023, Calm has launched Sleep Stories for Kids this feature on the Calm app offers guided meditations and bedtime stories specifically designed for children, promoting relaxation and healthy sleep habits in young minds.


Key Target Audience
Behavioral Health Vendors/Service Providers, Healthcare IT Service Providers, Research and Consulting Firms, Healthcare insurance companies/payers, Healthcare institutions/providers, Venture capitalists, Government agencies, Health information exchanges and Accountable care organizations (ACOs)

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Depression
  • Anxiety
  • Schizophrenia
  • Alcohol Use Disorders
  • Others
By Service
  • Emergency Mental Health Services
  • Outpatient Counseling
  • Home-Based Treatment Services
  • Inpatient Hospital Treatment Services
  • Preventative Programs

By Age Group
  • Pediatric Mental Health
  • Adult Mental Health
  • Geriatric Mental Health

By Disorder
  • Mental Health
  • Substance Abuse
  • Trauma and PTSD

By Payor
  • Public Health Insurance
  • Private Health Insurance
  • Out of Pockets

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of People Who Are Suffering From Behavioral Health
      • 3.2.2. Growing Accessibility of Therapies for Behavioral Health
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Awareness in Developing Countries
      • 3.3.2. Time-Consuming Procedures
    • 3.4. Market Trends
      • 3.4.1. Increasing Preferences of Partial Hospitalization Programs (PHP)
      • 3.4.2. Advent of Online Counselling
      • 3.4.3. Emergence of Behavioral Software
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Behavioral Health, by Type, Service, Age Group, Disorder, Payor and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Behavioral Health (Value)
      • 5.2.1. Global Behavioral Health by: Type (Value)
        • 5.2.1.1. Depression
        • 5.2.1.2. Anxiety
        • 5.2.1.3. Schizophrenia
        • 5.2.1.4. Alcohol Use Disorders
        • 5.2.1.5. Others
      • 5.2.2. Global Behavioral Health by: Service (Value)
        • 5.2.2.1. Emergency Mental Health Services
        • 5.2.2.2. Outpatient Counseling
        • 5.2.2.3. Home-Based Treatment Services
        • 5.2.2.4. Inpatient Hospital Treatment Services
        • 5.2.2.5. Preventative Programs
      • 5.2.3. Global Behavioral Health by: Age Group (Value)
        • 5.2.3.1. Pediatric Mental Health
        • 5.2.3.2. Adult Mental Health
        • 5.2.3.3. Geriatric Mental Health
      • 5.2.4. Global Behavioral Health by: Disorder (Value)
        • 5.2.4.1. Mental Health
        • 5.2.4.2. Substance Abuse
        • 5.2.4.3. Trauma and PTSD
      • 5.2.5. Global Behavioral Health by: Payor (Value)
        • 5.2.5.1. Public Health Insurance
        • 5.2.5.2. Private Health Insurance
        • 5.2.5.3. Out of Pockets
      • 5.2.6. Global Behavioral Health Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Behavioral Health: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Eli Lilly and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AstraZeneca PLC (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer Inc.(United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. NeuroSky (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Masimo Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cephalon (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GlaxoSmithKline plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Behavioral Health Sale, by Type, Service, Age Group, Disorder, Payor and Region (value) (2024-2029)
    • 7.1. Introduction
    • 7.2. Global Behavioral Health (Value)
      • 7.2.1. Global Behavioral Health by: Type (Value)
        • 7.2.1.1. Depression
        • 7.2.1.2. Anxiety
        • 7.2.1.3. Schizophrenia
        • 7.2.1.4. Alcohol Use Disorders
        • 7.2.1.5. Others
      • 7.2.2. Global Behavioral Health by: Service (Value)
        • 7.2.2.1. Emergency Mental Health Services
        • 7.2.2.2. Outpatient Counseling
        • 7.2.2.3. Home-Based Treatment Services
        • 7.2.2.4. Inpatient Hospital Treatment Services
        • 7.2.2.5. Preventative Programs
      • 7.2.3. Global Behavioral Health by: Age Group (Value)
        • 7.2.3.1. Pediatric Mental Health
        • 7.2.3.2. Adult Mental Health
        • 7.2.3.3. Geriatric Mental Health
      • 7.2.4. Global Behavioral Health by: Disorder (Value)
        • 7.2.4.1. Mental Health
        • 7.2.4.2. Substance Abuse
        • 7.2.4.3. Trauma and PTSD
      • 7.2.5. Global Behavioral Health by: Payor (Value)
        • 7.2.5.1. Public Health Insurance
        • 7.2.5.2. Private Health Insurance
        • 7.2.5.3. Out of Pockets
      • 7.2.6. Global Behavioral Health Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Behavioral Health: by Type(USD Million)
  • Table 2. Behavioral Health Depression , by Region USD Million (2018-2023)
  • Table 3. Behavioral Health Anxiety , by Region USD Million (2018-2023)
  • Table 4. Behavioral Health Schizophrenia , by Region USD Million (2018-2023)
  • Table 5. Behavioral Health Alcohol Use Disorders , by Region USD Million (2018-2023)
  • Table 6. Behavioral Health Others , by Region USD Million (2018-2023)
  • Table 7. Behavioral Health: by Service(USD Million)
  • Table 8. Behavioral Health Emergency Mental Health Services , by Region USD Million (2018-2023)
  • Table 9. Behavioral Health Outpatient Counseling , by Region USD Million (2018-2023)
  • Table 10. Behavioral Health Home-Based Treatment Services , by Region USD Million (2018-2023)
  • Table 11. Behavioral Health Inpatient Hospital Treatment Services , by Region USD Million (2018-2023)
  • Table 12. Behavioral Health Preventative Programs , by Region USD Million (2018-2023)
  • Table 13. Behavioral Health: by Age Group(USD Million)
  • Table 14. Behavioral Health Pediatric Mental Health , by Region USD Million (2018-2023)
  • Table 15. Behavioral Health Adult Mental Health , by Region USD Million (2018-2023)
  • Table 16. Behavioral Health Geriatric Mental Health , by Region USD Million (2018-2023)
  • Table 17. Behavioral Health: by Disorder(USD Million)
  • Table 18. Behavioral Health Mental Health , by Region USD Million (2018-2023)
  • Table 19. Behavioral Health Substance Abuse , by Region USD Million (2018-2023)
  • Table 20. Behavioral Health Trauma and PTSD , by Region USD Million (2018-2023)
  • Table 21. Behavioral Health: by Payor(USD Million)
  • Table 22. Behavioral Health Public Health Insurance , by Region USD Million (2018-2023)
  • Table 23. Behavioral Health Private Health Insurance , by Region USD Million (2018-2023)
  • Table 24. Behavioral Health Out of Pockets , by Region USD Million (2018-2023)
  • Table 25. South America Behavioral Health, by Country USD Million (2018-2023)
  • Table 26. South America Behavioral Health, by Type USD Million (2018-2023)
  • Table 27. South America Behavioral Health, by Service USD Million (2018-2023)
  • Table 28. South America Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 29. South America Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 30. South America Behavioral Health, by Payor USD Million (2018-2023)
  • Table 31. Brazil Behavioral Health, by Type USD Million (2018-2023)
  • Table 32. Brazil Behavioral Health, by Service USD Million (2018-2023)
  • Table 33. Brazil Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 34. Brazil Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 35. Brazil Behavioral Health, by Payor USD Million (2018-2023)
  • Table 36. Argentina Behavioral Health, by Type USD Million (2018-2023)
  • Table 37. Argentina Behavioral Health, by Service USD Million (2018-2023)
  • Table 38. Argentina Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 39. Argentina Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 40. Argentina Behavioral Health, by Payor USD Million (2018-2023)
  • Table 41. Rest of South America Behavioral Health, by Type USD Million (2018-2023)
  • Table 42. Rest of South America Behavioral Health, by Service USD Million (2018-2023)
  • Table 43. Rest of South America Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 44. Rest of South America Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 45. Rest of South America Behavioral Health, by Payor USD Million (2018-2023)
  • Table 46. Asia Pacific Behavioral Health, by Country USD Million (2018-2023)
  • Table 47. Asia Pacific Behavioral Health, by Type USD Million (2018-2023)
  • Table 48. Asia Pacific Behavioral Health, by Service USD Million (2018-2023)
  • Table 49. Asia Pacific Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 50. Asia Pacific Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 51. Asia Pacific Behavioral Health, by Payor USD Million (2018-2023)
  • Table 52. China Behavioral Health, by Type USD Million (2018-2023)
  • Table 53. China Behavioral Health, by Service USD Million (2018-2023)
  • Table 54. China Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 55. China Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 56. China Behavioral Health, by Payor USD Million (2018-2023)
  • Table 57. Japan Behavioral Health, by Type USD Million (2018-2023)
  • Table 58. Japan Behavioral Health, by Service USD Million (2018-2023)
  • Table 59. Japan Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 60. Japan Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 61. Japan Behavioral Health, by Payor USD Million (2018-2023)
  • Table 62. India Behavioral Health, by Type USD Million (2018-2023)
  • Table 63. India Behavioral Health, by Service USD Million (2018-2023)
  • Table 64. India Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 65. India Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 66. India Behavioral Health, by Payor USD Million (2018-2023)
  • Table 67. South Korea Behavioral Health, by Type USD Million (2018-2023)
  • Table 68. South Korea Behavioral Health, by Service USD Million (2018-2023)
  • Table 69. South Korea Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 70. South Korea Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 71. South Korea Behavioral Health, by Payor USD Million (2018-2023)
  • Table 72. Taiwan Behavioral Health, by Type USD Million (2018-2023)
  • Table 73. Taiwan Behavioral Health, by Service USD Million (2018-2023)
  • Table 74. Taiwan Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 75. Taiwan Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 76. Taiwan Behavioral Health, by Payor USD Million (2018-2023)
  • Table 77. Australia Behavioral Health, by Type USD Million (2018-2023)
  • Table 78. Australia Behavioral Health, by Service USD Million (2018-2023)
  • Table 79. Australia Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 80. Australia Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 81. Australia Behavioral Health, by Payor USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Behavioral Health, by Type USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Behavioral Health, by Service USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 85. Rest of Asia-Pacific Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 86. Rest of Asia-Pacific Behavioral Health, by Payor USD Million (2018-2023)
  • Table 87. Europe Behavioral Health, by Country USD Million (2018-2023)
  • Table 88. Europe Behavioral Health, by Type USD Million (2018-2023)
  • Table 89. Europe Behavioral Health, by Service USD Million (2018-2023)
  • Table 90. Europe Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 91. Europe Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 92. Europe Behavioral Health, by Payor USD Million (2018-2023)
  • Table 93. Germany Behavioral Health, by Type USD Million (2018-2023)
  • Table 94. Germany Behavioral Health, by Service USD Million (2018-2023)
  • Table 95. Germany Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 96. Germany Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 97. Germany Behavioral Health, by Payor USD Million (2018-2023)
  • Table 98. France Behavioral Health, by Type USD Million (2018-2023)
  • Table 99. France Behavioral Health, by Service USD Million (2018-2023)
  • Table 100. France Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 101. France Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 102. France Behavioral Health, by Payor USD Million (2018-2023)
  • Table 103. Italy Behavioral Health, by Type USD Million (2018-2023)
  • Table 104. Italy Behavioral Health, by Service USD Million (2018-2023)
  • Table 105. Italy Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 106. Italy Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 107. Italy Behavioral Health, by Payor USD Million (2018-2023)
  • Table 108. United Kingdom Behavioral Health, by Type USD Million (2018-2023)
  • Table 109. United Kingdom Behavioral Health, by Service USD Million (2018-2023)
  • Table 110. United Kingdom Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 111. United Kingdom Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 112. United Kingdom Behavioral Health, by Payor USD Million (2018-2023)
  • Table 113. Netherlands Behavioral Health, by Type USD Million (2018-2023)
  • Table 114. Netherlands Behavioral Health, by Service USD Million (2018-2023)
  • Table 115. Netherlands Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 116. Netherlands Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 117. Netherlands Behavioral Health, by Payor USD Million (2018-2023)
  • Table 118. Rest of Europe Behavioral Health, by Type USD Million (2018-2023)
  • Table 119. Rest of Europe Behavioral Health, by Service USD Million (2018-2023)
  • Table 120. Rest of Europe Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 121. Rest of Europe Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 122. Rest of Europe Behavioral Health, by Payor USD Million (2018-2023)
  • Table 123. MEA Behavioral Health, by Country USD Million (2018-2023)
  • Table 124. MEA Behavioral Health, by Type USD Million (2018-2023)
  • Table 125. MEA Behavioral Health, by Service USD Million (2018-2023)
  • Table 126. MEA Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 127. MEA Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 128. MEA Behavioral Health, by Payor USD Million (2018-2023)
  • Table 129. Middle East Behavioral Health, by Type USD Million (2018-2023)
  • Table 130. Middle East Behavioral Health, by Service USD Million (2018-2023)
  • Table 131. Middle East Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 132. Middle East Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 133. Middle East Behavioral Health, by Payor USD Million (2018-2023)
  • Table 134. Africa Behavioral Health, by Type USD Million (2018-2023)
  • Table 135. Africa Behavioral Health, by Service USD Million (2018-2023)
  • Table 136. Africa Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 137. Africa Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 138. Africa Behavioral Health, by Payor USD Million (2018-2023)
  • Table 139. North America Behavioral Health, by Country USD Million (2018-2023)
  • Table 140. North America Behavioral Health, by Type USD Million (2018-2023)
  • Table 141. North America Behavioral Health, by Service USD Million (2018-2023)
  • Table 142. North America Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 143. North America Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 144. North America Behavioral Health, by Payor USD Million (2018-2023)
  • Table 145. United States Behavioral Health, by Type USD Million (2018-2023)
  • Table 146. United States Behavioral Health, by Service USD Million (2018-2023)
  • Table 147. United States Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 148. United States Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 149. United States Behavioral Health, by Payor USD Million (2018-2023)
  • Table 150. Canada Behavioral Health, by Type USD Million (2018-2023)
  • Table 151. Canada Behavioral Health, by Service USD Million (2018-2023)
  • Table 152. Canada Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 153. Canada Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 154. Canada Behavioral Health, by Payor USD Million (2018-2023)
  • Table 155. Mexico Behavioral Health, by Type USD Million (2018-2023)
  • Table 156. Mexico Behavioral Health, by Service USD Million (2018-2023)
  • Table 157. Mexico Behavioral Health, by Age Group USD Million (2018-2023)
  • Table 158. Mexico Behavioral Health, by Disorder USD Million (2018-2023)
  • Table 159. Mexico Behavioral Health, by Payor USD Million (2018-2023)
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Behavioral Health: by Type(USD Million)
  • Table 169. Behavioral Health Depression , by Region USD Million (2024-2029)
  • Table 170. Behavioral Health Anxiety , by Region USD Million (2024-2029)
  • Table 171. Behavioral Health Schizophrenia , by Region USD Million (2024-2029)
  • Table 172. Behavioral Health Alcohol Use Disorders , by Region USD Million (2024-2029)
  • Table 173. Behavioral Health Others , by Region USD Million (2024-2029)
  • Table 174. Behavioral Health: by Service(USD Million)
  • Table 175. Behavioral Health Emergency Mental Health Services , by Region USD Million (2024-2029)
  • Table 176. Behavioral Health Outpatient Counseling , by Region USD Million (2024-2029)
  • Table 177. Behavioral Health Home-Based Treatment Services , by Region USD Million (2024-2029)
  • Table 178. Behavioral Health Inpatient Hospital Treatment Services , by Region USD Million (2024-2029)
  • Table 179. Behavioral Health Preventative Programs , by Region USD Million (2024-2029)
  • Table 180. Behavioral Health: by Age Group(USD Million)
  • Table 181. Behavioral Health Pediatric Mental Health , by Region USD Million (2024-2029)
  • Table 182. Behavioral Health Adult Mental Health , by Region USD Million (2024-2029)
  • Table 183. Behavioral Health Geriatric Mental Health , by Region USD Million (2024-2029)
  • Table 184. Behavioral Health: by Disorder(USD Million)
  • Table 185. Behavioral Health Mental Health , by Region USD Million (2024-2029)
  • Table 186. Behavioral Health Substance Abuse , by Region USD Million (2024-2029)
  • Table 187. Behavioral Health Trauma and PTSD , by Region USD Million (2024-2029)
  • Table 188. Behavioral Health: by Payor(USD Million)
  • Table 189. Behavioral Health Public Health Insurance , by Region USD Million (2024-2029)
  • Table 190. Behavioral Health Private Health Insurance , by Region USD Million (2024-2029)
  • Table 191. Behavioral Health Out of Pockets , by Region USD Million (2024-2029)
  • Table 192. South America Behavioral Health, by Country USD Million (2024-2029)
  • Table 193. South America Behavioral Health, by Type USD Million (2024-2029)
  • Table 194. South America Behavioral Health, by Service USD Million (2024-2029)
  • Table 195. South America Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 196. South America Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 197. South America Behavioral Health, by Payor USD Million (2024-2029)
  • Table 198. Brazil Behavioral Health, by Type USD Million (2024-2029)
  • Table 199. Brazil Behavioral Health, by Service USD Million (2024-2029)
  • Table 200. Brazil Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 201. Brazil Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 202. Brazil Behavioral Health, by Payor USD Million (2024-2029)
  • Table 203. Argentina Behavioral Health, by Type USD Million (2024-2029)
  • Table 204. Argentina Behavioral Health, by Service USD Million (2024-2029)
  • Table 205. Argentina Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 206. Argentina Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 207. Argentina Behavioral Health, by Payor USD Million (2024-2029)
  • Table 208. Rest of South America Behavioral Health, by Type USD Million (2024-2029)
  • Table 209. Rest of South America Behavioral Health, by Service USD Million (2024-2029)
  • Table 210. Rest of South America Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 211. Rest of South America Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 212. Rest of South America Behavioral Health, by Payor USD Million (2024-2029)
  • Table 213. Asia Pacific Behavioral Health, by Country USD Million (2024-2029)
  • Table 214. Asia Pacific Behavioral Health, by Type USD Million (2024-2029)
  • Table 215. Asia Pacific Behavioral Health, by Service USD Million (2024-2029)
  • Table 216. Asia Pacific Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 217. Asia Pacific Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 218. Asia Pacific Behavioral Health, by Payor USD Million (2024-2029)
  • Table 219. China Behavioral Health, by Type USD Million (2024-2029)
  • Table 220. China Behavioral Health, by Service USD Million (2024-2029)
  • Table 221. China Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 222. China Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 223. China Behavioral Health, by Payor USD Million (2024-2029)
  • Table 224. Japan Behavioral Health, by Type USD Million (2024-2029)
  • Table 225. Japan Behavioral Health, by Service USD Million (2024-2029)
  • Table 226. Japan Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 227. Japan Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 228. Japan Behavioral Health, by Payor USD Million (2024-2029)
  • Table 229. India Behavioral Health, by Type USD Million (2024-2029)
  • Table 230. India Behavioral Health, by Service USD Million (2024-2029)
  • Table 231. India Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 232. India Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 233. India Behavioral Health, by Payor USD Million (2024-2029)
  • Table 234. South Korea Behavioral Health, by Type USD Million (2024-2029)
  • Table 235. South Korea Behavioral Health, by Service USD Million (2024-2029)
  • Table 236. South Korea Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 237. South Korea Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 238. South Korea Behavioral Health, by Payor USD Million (2024-2029)
  • Table 239. Taiwan Behavioral Health, by Type USD Million (2024-2029)
  • Table 240. Taiwan Behavioral Health, by Service USD Million (2024-2029)
  • Table 241. Taiwan Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 242. Taiwan Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 243. Taiwan Behavioral Health, by Payor USD Million (2024-2029)
  • Table 244. Australia Behavioral Health, by Type USD Million (2024-2029)
  • Table 245. Australia Behavioral Health, by Service USD Million (2024-2029)
  • Table 246. Australia Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 247. Australia Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 248. Australia Behavioral Health, by Payor USD Million (2024-2029)
  • Table 249. Rest of Asia-Pacific Behavioral Health, by Type USD Million (2024-2029)
  • Table 250. Rest of Asia-Pacific Behavioral Health, by Service USD Million (2024-2029)
  • Table 251. Rest of Asia-Pacific Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 252. Rest of Asia-Pacific Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 253. Rest of Asia-Pacific Behavioral Health, by Payor USD Million (2024-2029)
  • Table 254. Europe Behavioral Health, by Country USD Million (2024-2029)
  • Table 255. Europe Behavioral Health, by Type USD Million (2024-2029)
  • Table 256. Europe Behavioral Health, by Service USD Million (2024-2029)
  • Table 257. Europe Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 258. Europe Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 259. Europe Behavioral Health, by Payor USD Million (2024-2029)
  • Table 260. Germany Behavioral Health, by Type USD Million (2024-2029)
  • Table 261. Germany Behavioral Health, by Service USD Million (2024-2029)
  • Table 262. Germany Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 263. Germany Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 264. Germany Behavioral Health, by Payor USD Million (2024-2029)
  • Table 265. France Behavioral Health, by Type USD Million (2024-2029)
  • Table 266. France Behavioral Health, by Service USD Million (2024-2029)
  • Table 267. France Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 268. France Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 269. France Behavioral Health, by Payor USD Million (2024-2029)
  • Table 270. Italy Behavioral Health, by Type USD Million (2024-2029)
  • Table 271. Italy Behavioral Health, by Service USD Million (2024-2029)
  • Table 272. Italy Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 273. Italy Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 274. Italy Behavioral Health, by Payor USD Million (2024-2029)
  • Table 275. United Kingdom Behavioral Health, by Type USD Million (2024-2029)
  • Table 276. United Kingdom Behavioral Health, by Service USD Million (2024-2029)
  • Table 277. United Kingdom Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 278. United Kingdom Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 279. United Kingdom Behavioral Health, by Payor USD Million (2024-2029)
  • Table 280. Netherlands Behavioral Health, by Type USD Million (2024-2029)
  • Table 281. Netherlands Behavioral Health, by Service USD Million (2024-2029)
  • Table 282. Netherlands Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 283. Netherlands Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 284. Netherlands Behavioral Health, by Payor USD Million (2024-2029)
  • Table 285. Rest of Europe Behavioral Health, by Type USD Million (2024-2029)
  • Table 286. Rest of Europe Behavioral Health, by Service USD Million (2024-2029)
  • Table 287. Rest of Europe Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 288. Rest of Europe Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 289. Rest of Europe Behavioral Health, by Payor USD Million (2024-2029)
  • Table 290. MEA Behavioral Health, by Country USD Million (2024-2029)
  • Table 291. MEA Behavioral Health, by Type USD Million (2024-2029)
  • Table 292. MEA Behavioral Health, by Service USD Million (2024-2029)
  • Table 293. MEA Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 294. MEA Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 295. MEA Behavioral Health, by Payor USD Million (2024-2029)
  • Table 296. Middle East Behavioral Health, by Type USD Million (2024-2029)
  • Table 297. Middle East Behavioral Health, by Service USD Million (2024-2029)
  • Table 298. Middle East Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 299. Middle East Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 300. Middle East Behavioral Health, by Payor USD Million (2024-2029)
  • Table 301. Africa Behavioral Health, by Type USD Million (2024-2029)
  • Table 302. Africa Behavioral Health, by Service USD Million (2024-2029)
  • Table 303. Africa Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 304. Africa Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 305. Africa Behavioral Health, by Payor USD Million (2024-2029)
  • Table 306. North America Behavioral Health, by Country USD Million (2024-2029)
  • Table 307. North America Behavioral Health, by Type USD Million (2024-2029)
  • Table 308. North America Behavioral Health, by Service USD Million (2024-2029)
  • Table 309. North America Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 310. North America Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 311. North America Behavioral Health, by Payor USD Million (2024-2029)
  • Table 312. United States Behavioral Health, by Type USD Million (2024-2029)
  • Table 313. United States Behavioral Health, by Service USD Million (2024-2029)
  • Table 314. United States Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 315. United States Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 316. United States Behavioral Health, by Payor USD Million (2024-2029)
  • Table 317. Canada Behavioral Health, by Type USD Million (2024-2029)
  • Table 318. Canada Behavioral Health, by Service USD Million (2024-2029)
  • Table 319. Canada Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 320. Canada Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 321. Canada Behavioral Health, by Payor USD Million (2024-2029)
  • Table 322. Mexico Behavioral Health, by Type USD Million (2024-2029)
  • Table 323. Mexico Behavioral Health, by Service USD Million (2024-2029)
  • Table 324. Mexico Behavioral Health, by Age Group USD Million (2024-2029)
  • Table 325. Mexico Behavioral Health, by Disorder USD Million (2024-2029)
  • Table 326. Mexico Behavioral Health, by Payor USD Million (2024-2029)
  • Table 327. Research Programs/Design for This Report
  • Table 328. Key Data Information from Secondary Sources
  • Table 329. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Behavioral Health: by Type USD Million (2018-2023)
  • Figure 5. Global Behavioral Health: by Service USD Million (2018-2023)
  • Figure 6. Global Behavioral Health: by Age Group USD Million (2018-2023)
  • Figure 7. Global Behavioral Health: by Disorder USD Million (2018-2023)
  • Figure 8. Global Behavioral Health: by Payor USD Million (2018-2023)
  • Figure 9. South America Behavioral Health Share (%), by Country
  • Figure 10. Asia Pacific Behavioral Health Share (%), by Country
  • Figure 11. Europe Behavioral Health Share (%), by Country
  • Figure 12. MEA Behavioral Health Share (%), by Country
  • Figure 13. North America Behavioral Health Share (%), by Country
  • Figure 14. Global Behavioral Health share by Players 2023 (%)
  • Figure 15. Global Behavioral Health share by Players (Top 3) 2023(%)
  • Figure 16. Global Behavioral Health share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Eli Lilly and Company (United States) Revenue: by Geography 2023
  • Figure 20. AstraZeneca PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. AstraZeneca PLC (United Kingdom) Revenue: by Geography 2023
  • Figure 22. Pfizer Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 23. Pfizer Inc.(United States) Revenue: by Geography 2023
  • Figure 24. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 26. NeuroSky (United States) Revenue, Net Income and Gross profit
  • Figure 27. NeuroSky (United States) Revenue: by Geography 2023
  • Figure 28. Masimo Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Masimo Corporation (United States) Revenue: by Geography 2023
  • Figure 30. Cephalon (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cephalon (United States) Revenue: by Geography 2023
  • Figure 32. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2023
  • Figure 34. Global Behavioral Health: by Type USD Million (2024-2029)
  • Figure 35. Global Behavioral Health: by Service USD Million (2024-2029)
  • Figure 36. Global Behavioral Health: by Age Group USD Million (2024-2029)
  • Figure 37. Global Behavioral Health: by Disorder USD Million (2024-2029)
  • Figure 38. Global Behavioral Health: by Payor USD Million (2024-2029)
  • Figure 39. South America Behavioral Health Share (%), by Country
  • Figure 40. Asia Pacific Behavioral Health Share (%), by Country
  • Figure 41. Europe Behavioral Health Share (%), by Country
  • Figure 42. MEA Behavioral Health Share (%), by Country
  • Figure 43. North America Behavioral Health Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Eli Lilly and Company (United States)
  • AstraZeneca PLC (United Kingdom)
  • Pfizer Inc.(United States)
  • Novartis AG (Switzerland)
  • NeuroSky (United States)
  • Masimo Corporation (United States)
  • Cephalon (United States)
  • GlaxoSmithKline plc (United Kingdom)
Additional players considered in the study are as follows:
Talkspace (United States) , Calm (United States) , GeneSight (United States) , Mindfull (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 225 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Behavioral Health Quantitative research analysis
Global Behavioral Health Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Eli Lilly and Company (United States), AstraZeneca PLC (United Kingdom), Pfizer Inc.(United States), Novartis AG (Switzerland), NeuroSky (United States), Masimo Corporation (United States), Cephalon (United States) and GlaxoSmithKline plc (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Preferences of Partial Hospitalization Programs (PHP) " is seen as one of major influencing trends for Behavioral Health Market during projected period 2023-2029.
The Behavioral Health market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Behavioral Health Report?

Have a Query? Click Here

Other Related Reports

Quadrivalent Flu Vaccine Comprehensive Study by Type (Intramuscular Injection, Nasal Spray, Intradermal Shot), Application (Hospital, Clinic, Public Health Agency, Other), Age Group (Adults, Pediatri...
$ 3500
Spine Osteoarthritis Comprehensive Study by Application (Hospitals and Clinics, Medical Institutes, Research Organization, Others), Treatment (Medication, Surgery, Therapy, Others), Diagnosis (Imagin...
$ 3450
Nasal Polyps Treatment Comprehensive Study by Application (Hospitals, Clinics, Research Center, Other), Treatment (Medications, Surgery), Diagnosis (CT Scan, MRI Scan, Other), Symptoms (Runny Nose, S...
$ 3450
Vitiligo Treatment Comprehensive Study by Type (Topical Treatment, Light Therapy, Surgical Procedures, Others), Application (Hospitals, Aesthetic Clinics, Others), Drugs (ARN-4079, ATI-50001, AX-1602...
$ 3650
Bulimia Nervosa Treatment Comprehensive Study by Therapy (Support group, Cognitive behavioral therapy, Cognitive therapy, Diaelectical behavior therapy, Counseling psychology, Family therapy, Others)...
$ 3750
Scoliosis Management Comprehensive Study by Type (Juvenile Idiopathic Scoliosis, Infantile Idiopathic Scoliosis, Adolescent Idiopathic Scoliosis), Application (Pediatric, Adult), Treatment (Painkilli...
$ 3450